Orthodontic Supplies Market - Global Industry Analysis, Size, Share and Growth, 2023

The global orthodontic supplies market is likely to grow from $3.4 billion in 2016 to $5.9 billion by 2023. The demand for orthodontic supplies is on a surge mainly due to increasing prevalence of oral diseases. Some of the most common oral diseases include dental cavities, periodontal diseases, oral cancer, malocclusions and other oral diseases and disorders. High prevalence of oral diseases depicts increased demand for orthodontic supplies. According to the World Health Organization (WHO), around 60% to 90% of the school children and nearly 100% of adults suffer from dental cavities. It has also been observed that, around 15% to 20% of adults aged between 35 to 44 years, suffer from severe periodontal (gum) disease.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/orthodontic-supplies-market/report-sample

As per the findings of the research, based on product, the fixed braces held the largest share in the global orthodontic supplies market, primarily due to their efficacy and precision in treating the irregularities in dental structure. Removable braces are expected to register the fastest growth in the orthodontics supplies market during the forecast period. The growth of the removable braces is primarily attributable to increase in the adoption of these braces by adults over traditional braces. Based on end user, children & teenagers are the larger end user in the orthodontic supplies market. Orthodontic treatments are more effective and successful in childhood or teenage as treatment at early age also prevents the development of serious problems, thereby leading to the larger adoption of orthodontic supplies at this age. The orthodontic supplies market for adults is expected to witness higher growth during the forecast period, mainly due to the increasing investment for the development of aesthetic braces and rising awareness about orthodontic treatment.

Cosmetic orthodontics is a procedure where the treatment is done to improve the appearance of a person’s gums, teeth and bite. The primary focus of the treatment is to alter the color, shape, and alignment of the teeth. With the growing inclination towards appearance, cosmetic orthodontics has become a preferable treatment option. Many technological advancements have been made in the orthodontics supplies products to make a person’s appearance better, both during and after the treatment. Some of these advancements include transparent brackets for professional look, colored brackets for children, and lingual brackets.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=orthodontic-supplies-market

Market players in the orthodontic supplies market are offering more advanced orthodontic supplies through increased number of acquisitions and product launches as their key strategies. In February 2017, Align technology, Inc. acquired Invisalign distributor Align Technology Do Brasil LTDA for the Brazil market. This acquisition helped the company to focus on the commercial, marketing and operational needs of doctors and potential patients in Brazil.

Some of the other key players operating in the orthodontics supplies market include 3M Company, Danaher Corporation, G&H Orthodontics Inc., American Orthodontics, TP Orthodontics Inc., Rocky Mountain Orthodontics, Dentaurum GmbH & Co. Kg and DB Orthodontics Inc.

Infection Surveillance Solutions Market - Global Industry Analysis, Growth and Demand, 2023

Infection is the invasion and multiplication of microorganisms such as viruses, bacteria and parasites that are not normally present within the human body. An infection may cause no symptoms and be hidden, or it may cause symptoms and be clinically visible. An infection may remain localized, or it may spread through the blood or lymphatic vessels to become systemic (present in the entire body). The global infection surveillance solutions market is growing due to the emergence of diseases caused by microorganisms that were previously not known. The microorganisms living naturally within the body are not considered as infectious for example, bacteria that normally live within the mouth and intestine such as E. coli do not cause an infection to the body. Hospital associated infections such as urinary tract infection, surgical site infections and pneumonia are increasing due to the use of contaminated devices, patient clothing, and other materials used in hospitals and clinics. This has thus provoked healthcare professionals and hospitals to adopt infection surveillance solutions to identify possible infections during the time the patient remains in hospital, and to develop necessary preventive measures for the same. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sterile medical devices.

Explore Report at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market

The growth in the global infection surveillance solutions market is expected to be mainly due to the increasing incidence of HAIs; policies introduced by government for preventing these HAIs; and increase in expenditure in healthcare sector. According to World Health Organization (WHO), 9.9% of the gross domestic product (GDP) of the world was spent on healthcare in 2014. Furthermore, cost-effectiveness, and redundancy of clinical data and the increase in number of surgeries drive the growth of infection surveillance solutions market.

The introduction of cloud-based software into the infection surveillance solutions market and high growth in developing countries across Asia-Pacific and Latin America provide vast area of opportunities for players in the infection surveillance solutions market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/infection-surveillance-solutions-market/report-sample

The key trend noticed in infection surveillance solutions market is the shift of healthcare providers towards automation in healthcare facilities and a growing demand for web-based solutions and mobile platforms. 

Some of the other key players in global market are, Premier Inc., Baxter International Inc., Gojo Industries, Inc., Truven Health Analytics (An IBM Company), DEB Group Ltd., Hygreen, Inc., Atlas Medical Software, and RL Solutions.

Europe Hospital Beds Market Regional Analysis with Type, Top Manufacturers, Demand, Applications till 2022

The European hospital bed market achieved a value of $1.6 billion in the year 2015 and is forecasted to grow at a CAGR of 4.3% during 2016-2022. Depending upon the usage, there are variety of hospital beds that are available in the regional market such as general, birthing, pediatric, bariatric, pressure relief and others. Amongst the various types, general beds held the largest share of the market, and is expected to attain a value of $854.4 million by 2022, growing at a CAGR of 4.8%. The category is also expected to witness the fastest growth during the forecast period, since general beds are used for all types of patients. The hospital bed market in the region has been growing due to several factors such as increasing healthcare expenditure, growing aging population, increasing prevalence of chronic diseases and ongoing technological advancements the market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/europe-hospital-beds-market

The government of various countries are investing in healthcare expenditure, due to which the companies are focusing more on providing best facilities to the patients by developing innovative solutions for better care. For instance, in May 2017, Hill-Rom Holdings, Inc., unveiled its new Hill-Rom Envella Air Fluidized Therapy Bed, which is an advanced solution for wound care for patients with advanced wounds. The Envella bed's differentiated technology provides an ideal healing environment for the prevention and treatment of advanced pressure injuries. Following that Howard Wright Limited launched a new ward bed M10, in July 2016, which can revolutionize patient care and safety. M10 has the most demanding standards and is made to focus on three key areas of concern namely, patient falls, pressure injuries and cross infection.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/europe-hospital-beds-market/report-sample

Some of the key players operating in the regional hospital bed market are Hill-Rom Holdings, Inc., Stryker Corporation, Getinge AB, LINET spol. s.r.o., Howard Wright Limited, Drive DeVilbiss Healthcare, Sunflower Medical Ltd., Stiegelmeyer GmbH & Co. KG, Merivaara Corp., and Alpha-Fit GmbH.

Mobile Health Industry Trends, Analysis, Growth and Future Scope

Mobile health market was valued at $13,674.3 million in 2015, and it is expected to grow at a CAGR of 34.0% during 2016 - 2022. Among the various products and services, the mHealth application segment is expected to witness the fastest growth, at a CAGR of 40.1%, during the forecast period. The global mhealth market is growing at a significant rate, due to increasing healthcare cost, increasing demand for patient centric healthcare model, and increasing prevalence of chronic and lifestyle associated diseases. In addition, the growing demand for mhealth technologies, increasing access of mobile platforms, tablets and smartphones, increasing utilization of connected medical devices and mhealth applications, and growing need for remote patient monitoring services are also driving the growth of the global mhealth market.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/mobile-healthcare-market

Mobile health (mHealth) is the use of mobile information and communication technologies for improving healthcare. It helps to tackle major challenges faced by the healthcare industry such as regulatory changes, continuous remote monitoring at home, increasing demand for quality healthcare, increasing error occurrence and integration with existing IT systems.

Geographically, North America dominated the global market of mhealth in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, CAGR of 40.5%, during the forecast period.

Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/mobile-healthcare-market/report-sample

Some of the key companies operating in the global mhealth market include LifeWatch AG, Cisco Systems Inc., Cerner Corporation, OMRON Corporation, AT&T Inc., athenahealth Inc., Airstrip Technologies Inc., AliveCor Inc., AgaMatrix Inc., iHealth Labs Inc., Koninklijke Philips N.V., BioTelemetry Inc., Medtronic PLC, Withings SAS, and Johnson & Johnson.

Breast Cancer Market - Global Industry Analysis, Size and Growth, 2023

Cancer is a disease characterized by uncontrolled growth of cell. There are about 100 different types of cancer and each is classified by the type of cell where it occurs and affects. Breast cancer is mostly prevalent in women, however, breast cancer in men is rare. It is frequently diagnosed in aged women and one of the leading causes of death among them. Some of the most common types of breast cancer are ductal carcinoma in situ (DCIS), lobular carcinoma and invasive ductal carcinoma.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market/report-sample

DCIS, also known as intraductal carcinoma, begins in the lining of the milk ducts. Milk ducts are thin tubes carrying milk from lobules of the breast to the nipple. Lobule carcinoma originates in the lobules or milk glands of the breast. Invasive ductal carcinoma is the most common type of breast cancer. It starts in a milk duct of the breast, ruptures through the wall of the duct and grows into the fatty tissue of the breast. It spreads to other parts of body through bloodstream.

The global breast cancer market covers various diagnostic technologies and therapeutic drugs. Diagnostic segment is further sub-segmented into various tests which are used to diagnose breast cancer. Some of the major diagnostic tests are biopsy, mammography, MRI, etc. Therapeutic segment covers hormone therapies and chemotherapy drugs. Some of the major drugs are Trastuzumab, Bevacizumab, Anastrozole, Capecitabine, Carboplatin, Denosumab, Docetaxel, Doxorubicin, Eribulin, Exemestane, Fluorouracil, Fulvestrant, Gemcitabine, Ixabepilone, Lapatinib, Letrozole, Methotrexate, Paclitaxel and Tamoxifen.

For more information visit: https://www.psmarketresearch.com/market-analysis/-breast-cancer-market

Some of the major competitors in the market are Astrazeneca PLC, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Novartis AG, Sanofi-Aventis. Pfizer, Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.

Healthcare/Medical Simulation Market Analysis, Size, Growth and Demand, 2023

The global healthcare/medical simulation market is growing significantly due to technological advancements and increasing demand for minimally invasive procedures. Massive unexplored healthcare/medical simulation market in emerging economies and lack of service providers are creating ample opportunities for the global healthcare/medical simulation market to grow at a considerable rate in the coming years. However, lack of adequate input data for medical simulation models is a major challenge in the global healthcare and medical simulation market. Medical simulation trains medical professionals to minimise errors during surgical procedures by using advanced techniques of simulation. The simulated animations help students to understand the complexity of medical procedures through computer-based virtual patients.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/healthcare-simulation-market/report-sample

Adoption of medical simulation technology in hospitals and academic institutes worldwide in order to reduce the medical errors and improve patient safety is a trend in healthcare/medical simulation market. Deaths occurring due to medical mistakes are major concern across the globe. According to a report published in September 2013, in the Journal of Patient Safety, more than 440,000 people die every year due to preventable medical errors. Healthcare simulation may simulate critical medical conditions without any harm to patients; this in turn helps medical professionals to evaluate their practices and reduce their mistakes. Medical simulation is capable of reproducing critical events over and over again and hence, explores consequences of each error or mistake made.

Geographically, North America will be leading the global healthcare/medical simulation market in the coming years, due to technological advancements, high healthcare expenditure, and presence of a large number of hospitals and academic institutions. In addition, Patient Safety and Quality Improvement Act in the U.S. is also driving its market in North America region. Asia-Pacific is the fastest growing region in the global healthcare/medical simulation market. The major reasons for the fastest growth in the region are improving healthcare infrastructure and increasing demand for minimally invasive procedures.

Explore Report at: https://www.psmarketresearch.com/market-analysis/healthcare-simulation-market

Some of the major players operating in the global healthcare/medical simulation market are Laerdal Medical As, 3D Systems, Inc., CAE, Inc., Kyoto Kagaku Co., Ltd., Limbs & Things, Ltd., Gaumard Scientific Company, Inc., Simulab Corporation, Surgical Science Sweden Ab, and Mentice Ab.

Biosimulation Technology Market - Global Industry Insights, Analysis and Growth, 2023

The global biosimulation market is growing significantly due to technological advancements and increasing research and development investment in the pharmaceutical and biotechnology industries. Low success rate of drug approval and emerging software applications of biosimulation technology are creating ample opportunities for the global biosimulation technology market to grow at a significant rate in the forecasted period.The advanced research and development facilities and new product developments by the companies are propelling the demand for cost effective biosimulation software.

In biosimulation industry, there is a trend of collaboration and partnership of universities and research institutes with suppliers. Drug discovery and development process is stringent, time consuming, and expensive process. In addition, the success rate of drug approval is very low. According to Tufts Centre for the Study of Drug Development, an academic, non-profit research group at Tufts University, in the U.S., out of 1,000 compounds tested only one makes it to human clinical trials, and out of five such compounds only one gets approved. Biosimulation technology overcomes these limitations by simulating biological systems through software models and increasing predictability in early stages of drug development; hence, saving time and money in drug development process.

Explore Report at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market

Biosimulation technology market can be categorized on the basis of applications, end-users, and product types. Based on applications, the biosimulation technology market can be categorized as drug development, drug discovery, and others. Drug development segment includes preclinical testing and clinical trials; whereas, drug discovery segment includes target identification and validation, and lead identification and optimization. Drug development segment leads the biosimulation technology market. Based on end-users, biosimulation technology market can be categorized as pharmaceutical and biotechnology companies, academic institutes and research laboratories, contract research organizations, and others. Pharmaceutical and biotechnology companies lead the biosimulation technology market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/biosimulation-technology-market/report-sample

Some of the major players operating in the global biosimulation technology market Dassault Systemes SA, Simulation Plus Inc., Certara USA, Inc., Advanced Chemistry Development, Inc., In Silico Biosciences, Inc., Chemical Computing Group, Inc., Physiomics PLC., Rhenovia Pharma Ltd., Genedata AG, Entelos Holding Corporation, Leadscope, Inc., and Schrodinger Inc. among others.

Key Growth Factors in Vaccine Market that has a huge impact on Medical Industry

The global vaccine market is growing significantly due increasing initiatives by non-government organizations to provide immunization and improvement in production technique of vaccine in the industry. Various programs and campaigns are organized, such as Immunization Week by World Health Organization, to create awareness among the population all over the world. Massive unexplored market in vaccine industry of developing economies are creating ample opportunities for the vaccine market to grow at a considerable rate in the coming years.

Explore Report at: https://www.psmarketresearch.com/market-analysis/vaccine-market

Moreover, the advanced research and development facilities, and new and innovative product developments by the companies are propelling the growth of the vaccine industry. Increasing prevalence of cancer and infectious diseases is fuelling the growth of the vaccine market. Infectious diseases are the major contributor to the human mortality and morbidity. According to World Health Organization, approximately 129,064 cases were reported in 2013. Vaccination has rescued millions of lives to provide secure and better life.

The vaccine market is categorized on the basis of type, technology, disease indication and end users. On the basis of type of vaccine, the vaccine market can be categorized as preventive vaccine and therapeutic vaccine. Preventive vaccine leads the vaccine market due to increasing prevalence of infectious disease and increasing investment by government and non-government organizations.

Explore report Sample at: https://www.psmarketresearch.com/market-analysis/vaccine-market/report-sample

Some of the companies operating in the global vaccine market are GlaxoSmithKline, Plc., CSL Limited, Sanofi, Medimmune, LLC., Emetgent Biosolutions, Inc., Novartis, AG, Pfizer, Inc., Merck & Co., Inc., Bavarian Nordic, and Johnson & Johnson.